IR Stock Analysis: Ingersoll Rand | NYSE
Specialty Industrial Machinery | NYSE, USA | Market Cap: 33.029m USD | 12M Return: 15.5% | US45687V1061 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 348M
EPS Trend: 83.2%
Qual. Beats: 0
Rev. Trend: 99.2%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 9.2 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Ingersoll Rand Inc. (NYSE: IR) is a diversified industrial manufacturer providing mission-critical air, fluid, clean energy, and medical technologies and services worldwide. Founded in 1859 and headquartered in Davidson, North Carolina, the company operates through two reportable segments: Industrial Technologies and Services and Precision and Science Technologies.
The Industrial Technologies and Services segment designs, manufactures, and services air and gas compression and treatment equipment, vacuum and blower products, fluid transfer equipment, loading systems, and power tools and lifting equipment under brands such as Ingersoll Rand, Gardner Denver, Nash, CompAir, and Elmo Rietschle. The Precision and Science Technologies segment produces diaphragm, piston, water-powered, peristaltic, gear, vane, progressive cavity, and syringe pumps, along with hydrogen compression systems, liquid handling systems, and odorant injection systems under brands including ARO, Dosatron, Haskel, Milton Roy, Seepex, Thomas, Welch, and Williams. Products are sold through a mix of direct sales representatives and independent distributors, serving end markets such as medical, laboratory, industrial manufacturing, water and wastewater, chemical processing, clean energy, food and beverage, and agriculture.
The company maintains a strategic alliance with Garrett Motion and was formerly known as Gardner Denver Holdings, Inc., rebranding to Ingersoll Rand in March 2020. As a participant in the industrial machinery and components subsector, the business combines original equipment manufacturing with aftermarket parts, consumables, and service offerings, a model that typically generates recurring revenue tied to its global installed base.
- Data center expansion boosts compressor and blower orders
- Bolt-on M&A pipeline expands precision pump and clean energy platforms
- Aftermarket service revenue drives margin expansion and recurring growth
| Net Income: 959.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -0.82 > 1.0 |
| NWC/Revenue: 20.58% < 20% (prev 31.99%; Δ -11.41% < -1%) |
| CFO/TA 0.07 > 3% & CFO 1.35b > Net Income 959.1m |
| Net Debt (4.37b) to EBITDA (1.97b): 2.22 < 3 |
| Current Ratio: 1.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (392.0m) vs 12m ago -2.11% < -2% |
| Gross Margin: 37.94% > 18% (prev 43.74%; Δ -5.79% > 0.5%) |
| Asset Turnover: 43.82% > 50% (prev 40.78%; Δ 3.04% > 0%) |
| Interest Coverage Ratio: 5.70 > 6 (EBIT TTM 1.47b / Interest Expense TTM 257.1m) |
| A: 0.09 (Total Current Assets 4.29b - Total Current Liabilities 2.65b) / Total Assets 18.2b |
| B: 0.19 (Retained Earnings 3.49b / Total Assets 18.2b) |
| C: 0.08 (EBIT TTM 1.47b / Avg Total Assets 18.1b) |
| D: 1.28 (Book Value of Equity 10.2b / Total Liabilities 7.95b) |
| Altman-Z'' = 3.10 = A |
| DSRI: 1.01 (Receivables 1.51b/1.39b, Revenue 7.94b/7.36b) |
| GMI: 1.15 (GM 43.74% / 37.94%) |
| AQI: 0.99 (AQ_t 0.71 / AQ_t-1 0.72) |
| SGI: 1.08 (Revenue 7.94b / 7.36b) |
| TATA: -0.02 (NI 959.1m - CFO 1.35b) / TA 18.2b) |
| Beneish M = -2.83 (Cap -4..+1) = A |
As of August 07, 2026, the stock is trading at USD 88.24 with a total of 5,226,424 shares traded. Over the past week, the price has changed by +4.65%, over one month by +9.44%, over three months by +12.22% and over the past year by +15.49%.
Current recommended Stop Loss: 84.60 (which is 4.1% or 1.3 ATR below the current price).
Ingersoll Rand has received a consensus analysts rating of 3.94. Therefore, it is recommended to buy IR.
- StrongBuy: 7
- Buy: 2
- Hold: 8
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 93.6 | 6.1% |
P/E Trailing = 56.973
P/E Forward = 24.4499
P/S = 4.3266
P/B = 3.2541
P/EG = 0.8071
Revenue TTM = 7.94b USD
EBIT TTM = 1.47b USD
EBITDA TTM = 1.97b USD
Long Term Debt = 4.78b USD (from longTermDebt, last fiscal year)
Short Term Debt = 699.8m USD (from shortTermDebt, last quarter)
Debt = 5.55b USD (corrected: LT Debt 4.78b + ST Debt 699.8m) + Leases 64.8m
Net Debt = 4.37b USD (calculated: Debt 5.55b - CCE 1.17b)
Enterprise Value = 37.4b USD (33.0b + Debt 5.55b - CCE 1.17b)
Interest Coverage Ratio = 5.70 (Ebit TTM 1.47b / Interest Expense TTM 257.1m)
EV/FCF = 30.68x (Enterprise Value 37.4b / FCF TTM 1.22b)
FCF Yield = 3.26% (FCF TTM 1.22b / Enterprise Value 37.4b)
FCF Margin = 15.35% (FCF TTM 1.22b / Revenue TTM 7.94b)
Net Margin = 12.08% (Net Income TTM 959.1m / Revenue TTM 7.94b)
Gross Margin = 37.94% ((Revenue TTM 7.94b - Cost of Revenue TTM 4.93b) / Revenue TTM)
Gross Margin QoQ = 42.10% (prev 42.90%)
Tobins Q-Ratio = 2.06 (Enterprise Value 37.4b / Total Assets 18.2b)
Interest Expense / Debt = 4.63% (Interest Expense 257.1m / Debt 5.55b)
Taxrate = 20.24% (245.1m / 1.21b)
NOPAT = 1.17b (EBIT 1.47b * (1 - 20.24%))
Current Ratio = 1.62 (Total Current Assets 4.29b / Total Current Liabilities 2.65b)
Debt / Equity = 0.55 (Debt 5.55b / totalStockholderEquity, last quarter 10.2b)
Debt / EBITDA = 2.22 (Net Debt 4.37b / EBITDA 1.97b)
Debt / FCF = 3.59 (Net Debt 4.37b / FCF TTM 1.22b)
Total Stockholder Equity = 10.1b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.29% (Net Income 959.1m / Total Assets 18.2b)
RoE = 9.46% (Net Income TTM 959.1m / Total Stockholder Equity 10.1b)
RoCE = 9.83% (EBIT 1.47b / Capital Employed (Equity 10.1b + L.T.Debt 4.78b))
RoIC = 7.38% (NOPAT 1.17b / Invested Capital 15.8b)
WACC = 8.79% (E(33.0b)/V(38.6b) * Re(9.65%) + D(5.55b)/V(38.6b) * Rd(4.63%) * (1-Tc(0.20)))
Discount Rate = 9.65% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -93.94 | Cagr: -1.78%
[DCF] Terminal Value 72.31% ; FCFF base≈1.27b ; Y1≈1.17b ; Y5≈1.04b
[DCF] Fair Price = 27.95 (EV 15.3b - Net Debt 4.37b = Equity 10.9b / Shares 391.3m; r=8.79% [WACC]; 5y FCF grow -10.19% → 2.50% )
EPS Correlation: 83.20 | EPS CAGR: 5.32% | SUE: 0.71 | # QB: 0
Revenue Correlation: 99.20 | Revenue CAGR: 5.92% | SUE: 3.60 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.91 | Chg30d=+0.85% | Revisions=-40% | Analysts=5
EPS current Year (2026-12-31): EPS=3.52 | Chg30d=+0.45% | Revisions=+0% | GrowthEPS=+5.4% | GrowthRev=+4.3%
EPS next Year (2027-12-31): EPS=3.85 | Chg30d=-0.02% | Revisions=-40% | GrowthEPS=+9.4% | GrowthRev=+4.0%
[Analyst] Revisions Ratio: -44% (up=1, down=5)